SUGDIS
Publication Issue Titles
2006
To jump to a specific SUGDIS publication, click on the title:
CLIPs--Current Literature and
Information for Pharmacists
New Drug FAX Sheet
Pharmacy Precis
Index, 4th Qtr
CLIPs--Current Literature and Information for Pharmacists:
2006, Vol 10
|
Issue
|
Date |
Title |
67 |
Dec 25 | Drug-Induced Emergency Department visits |
66 |
Dec 18 | Child and Adolescent Food and Nutrition Programs |
65 |
Dec 4 | Pressure Ulcer Guideline Review |
64 |
Nov 27 | Assessment of GI Bleeding Risk with Low-Dose Aspirin |
63 |
Nov 20 | Assessment of Renal Function in Clinical Practice |
62 |
Nov 8 | Current Trends in Treating Osteoporosis |
61 |
Nov 6 | Diagnosis and Management of Anaphylaxis |
60 |
Oct 30 | Drug Overdose & Antidotes |
59 |
Oct 27 | Atypical Antipsychotics and Alzheimer's Disease |
58 |
Oct 23 | Benefits and Safety of Intensive Statin Therapy |
57 |
Oct 16 | NIH Recommendations for Multivitamin/Mineral Supplements to Prevent Chronic Diseases |
56 |
Oct 13 | Influenza Vaccination for Patients with CVD |
55 |
Oct 2 | Management of Atrial Fibrillation: 2006 ACC/AHA/ESC Guidelines |
54 |
Sep 25 | Improved Aminosalicylate Formulations to Treat UC |
53 |
Sep 18 | Updated CDC Guidelines: Treatment of Sexually Transmitted Diseases |
| 52 |
Sep 11 |
Fluoroqinolones' Activity vs. Anaerobes |
| 51 |
Sep 8 |
Useful Alternative for Post-Op Nausea and Vomiting |
| 50 |
Sep 4 |
Initial Insulin Therapy Guidelines for Diabetic Patients |
| 49 |
Aug 21 |
GERD: Diagnosis and Treatment |
| 48 |
Aug 14 |
Obesity: A Matter of Public Health? |
| 47 |
Aug 11 |
Non-Estrogen Therapies for Menopausal Hot Flashes |
| 46 |
Aug 9 |
Long-Term Safety of Bisphosphonate Therapy |
| 45 |
Jul 31 |
Updated AHA Guidelines: Pediatric Basic Life Support |
| 44 |
Jul 27 |
|
| 43 |
Jul 25 |
Falls Prevention in Ling-Term Care: An Interdisciplinary Aproach |
| 42 |
Jul 24 |
Updated Secondary Prevention Guidelines |
| 41 |
Jul 17 |
ASHP Position Statement: 0.9% Sodium Chloride Use to Maintain Catheter Patenc |
| 40 |
Jul 14 |
Another Raloxifene Breast Cancer Prevention Study |
| 39 |
Jul 7 |
Raloxifene for Breast Cancer Prevention |
| 38 |
Jul 3 |
Current Antifungal Therapy |
| 37 |
Jun 26 |
Review of Clinical Pharmacists Value in Inpatient Medical Care |
| 36 |
Jun 22 |
Neuroprotective Strategies for Parkinson Disease |
| 35 |
Jun 19 |
AHA / ASA Guidelines for Stroke Prevention |
| 34 |
Jun 12 |
Pharmacists and Cardiovascular Disease |
| 33 |
Jun 5 |
Restless Legs Syndrome and Periodic Limb Movement Disorder |
| 32 |
May 29 |
Obesity and Weight Loss: A Review of Drug Safety |
| 31 |
May 22 |
|
| 30 |
May 8 |
Issues of Pediatric Sedation and Analgesia |
| 29 |
May 1 |
Disinfecting Agents, Procedures, & Requirements for Cleanrooms |
| 28 |
Apr 27 |
Pressure Ulcer Assessment & Guidelines |
| 27 |
Apr 26 |
Preventing and Treating Pressure Ulcers |
| 26 |
Apr 25 |
Aspirin and NSAIDs: Physician Perceptions |
| 25 |
Apr 24 |
Soy Proteins and Isoflavones, Are These Beneficial? |
| 24 |
Apr 17 |
Treatment Update for Sinusitis Management |
| 23 |
Apr 10 |
Osteoporosis Management in te Elderly |
| 22 |
Apr 3 |
Allergies and Antibiotics |
| 21 |
Mar 28 |
Bad Bugs, Bad Bugs, Whatcha Gonna Do? |
| 20 |
Mar 27 |
Urinary Incontinence |
| 19 |
Mar 23 |
|
| 18 |
Mar 21 |
Anti-IgE for Asthma Therapy |
| 17 |
Mar 20 |
A Guide to Dietary Recommendations for Youth |
| 16 |
Mar 16 |
Clopidogrel (Plavix®) in the News |
| 15 |
Mar 6 |
Limited Adverse Events with Excessive Anticoagulation |
| 14 |
Mar 6 |
Treating Excessive Anticoagulation with Vitamin K |
| 13 |
Mar3 |
NSAID Use in High-Risk Patients |
| 12 |
Mar 1 |
Interaction Between Linezolid and SSRI |
| 11 |
Feb 27 |
Methamphetamine Abuse |
| 10 |
Feb 20 |
Updated ACCP Guidelines: Cough Suppressant and Protussive Therapy |
| 9 |
Feb 13 |
Clarification of Drug Safety Terms |
| 8 |
Feb 3 |
Treating Elderly Patients with Diabetes |
| 7 |
Feb 2 |
ASHP's Statement Regarding OTC Statins |
| 6 |
Jan 30 |
Drug-Induced Emergency Room Visits |
| 5 |
Jan 27 |
Panel Recommendations for Factor VIIA Use |
| 4 |
Jan 23 |
Nesiritide Use in Outpatient Setting |
| 3 |
Jan 17 |
A Year in Review: Heart Failure 2005 and Beyond |
| 2 |
Jan 9 |
Candida and Invasive Mold Infections |
| 1 |
Jan 2 |
Diabetic Foot Ulcers |
New Drug FAX Sheet:
2006, Vol 11
| Issue
|
Date |
Title |
52 |
Dec 19 | FDA Alert for Viral Infection of the Brain After Rituximab (Rituxan®) Administration |
51 |
Dec 13 | FDA Warns Against Unlabeled Drugs Uses for Quinine Products |
50 |
Dec 11 | New Drug Approvals |
49 |
Nov 28 | Serious Adverse Effects Associated with Methadone Therapy |
48 |
Nov 17 | Serious Cardiovascular Complications Associated with Erythropoiesis-Stimulating Agents at Higher Target Hemoglobin Concentrations |
47 |
Nov 14 | Tamiflu (Oseltamivir) Neuropsychiatric Events in Children |
46 |
Nov 13 | New Drug Approvals |
45 |
Nov 10 | Acetaminophen Recall |
44 |
Oct 9 | New Drug Approvals |
43 |
Oct 2 | Trasylol® Warning |
42 |
Sep 25 | Ortho Evra Warning |
| 41 |
Sep 14 |
Ibuprofen
and Aspirin Combination Warning |
| 40 |
Sep 14 |
Dietary
Supplements Seized |
| 39 |
Sep 7 |
Dietary Supplements with Ephedrine Banned |
| 38 |
Aug 28 |
|
| 37 |
Aug 22 |
New Warnings for Stimulants |
| 36 |
Aug 11 |
Hydralazine Injection Recall |
| 35 |
Aug 7 |
New Drug Approvals, Formulations, and Indications |
| 34 |
Jul 20 |
Serotonin Syndrome Associated with Concomitant Use of Triptans and SSRIs or SNRIs |
| 33 |
Jul 20 |
Adverse Effects Associated with SSRI Treatment in Pregnancy |
| 32 |
Jul 11 |
Oxybutynin Transdermal (Oxytrol®, Watson Pharma) |
| 31 |
Jul 10 |
|
| 30 |
Jul 3 |
Intracranial Hemorrhage Associated with Tipranavir (Aptivus®) Use |
| 29 |
Jun 30 |
FDA Issues Warnings of Liver Toxicity for Telithromycin (Ketek®) |
| 28 |
Jun 23 |
Tequin® (Gatifloxacin) Discontinued |
| 27 |
Jun 7 |
Resumed Marketing of Natalizumab (Tysabri®) |
| 26 |
May 18 |
Exubera® (Insulin Human [RDNA Origin] Inhalation Powder) |
| 25 |
May 15 |
|
| 24 |
May 8 |
Phosphate Nephropathy and oral Sodium Phosphates |
| 23 |
Apr 26 |
Promethazine and Respiratory Depression |
| 22 |
Apr 10 |
Reports of Anaphylaxis with Macugen® (Pegaptanib) Therapy |
| 21 |
Apr 10 |
|
| 20 |
Mar 31 |
New Information Concerning Diastat® AcuDial (Diazepam Rectal Gel) Administration |
| 19 |
Mar 17 |
Two Additional Fatalities Associated with Mifepristone (Mifeprex®) for Medical Abortion |
| 18 |
Mar 16 |
Denileukin Difititox (Ontak®)--Associated Visual Loss |
| 17 |
Mar 13 |
|
| 16 |
Mar 1 |
Cefazolin for Injection Recall Due to Microbial Contamination |
| 15 |
Feb 22 |
Investigational Oral Anticoagulants |
| 14 |
Feb 17 |
Ximelagatran (Exanta®) Approval Application Withdrawn |
| 13 |
Feb 17 |
New Safety Alerts for Gatifloxacin (Tequin®) Tablets and Injection |
| 12 |
Feb 16 |
New Warnings for Nimodipine (Nimotop®) Capsules |
| 11 |
Feb 14 |
Recall of Balanced Salt Solutin from Cytosol Laboratories |
| 10 |
Feb 14 |
Benzocaine Sprays Used in the Mouth or Throat and Methemoglobinemia |
| 9 |
Feb 6 |
|
| 8 |
Jan 27 |
Hydroxyurea (Hydrea®) Associated with Vasculitic Ulcerations |
| 7 |
Jan 24 |
Ketek (Telithromycin) Associated with Liver Toxicity |
| 6 |
Jan 24 |
Elidel (Pimecrolimus) Reserved as a Second-Line Agent for Atopic Dermatitis |
| 5 |
Jan 18 |
Influenza Update: Amantadine and Rimantadine Not Recommended |
| 4 |
Jan 17 |
Dangerous Diet Pills |
| 3 |
Jan 17 |
Revisions to Clozaril® Package Labeling |
| 2 |
Jan 6 |
Intravascular Hemolyisis and Blood Glucose Alterations Associated with WinRho® SDF Therapy |
| 1 |
Jan 5 |
Rosiglitazone-Associated Diabetic Macular Edema |
Pharmacy Precis:
2006, Vol 24
| Issue
|
Date |
Title |
3 |
Oct | Advisory Committee on Immunization Practices (ACIP) Recommendations for the Prevention and Control of Influenza |
| 2 |
Jun |
SUGDIS 2005:Quality Assurance Survey Results |
| 1 |
Jan |
New Molecular Entities of 2005 |